Separate and combined effect of visit-to-visit glycaemic variability and mean fasting blood glucose level on all-cause mortality in patients with type 2 diabetes: A population-based cohort study
- PMID: 35876225
- DOI: 10.1111/dom.14826
Separate and combined effect of visit-to-visit glycaemic variability and mean fasting blood glucose level on all-cause mortality in patients with type 2 diabetes: A population-based cohort study
Abstract
Aims: To assess the independent and combined impacts of visit-to-visit fasting blood glucose variability (VVV-FBG) and mean fasting blood glucose level (M-FBG) on all-cause mortality.
Materials and methods: This prospective cohort study included 48 843 Chinese patients with type 2 diabetes. Cox proportional hazards regression models were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) to evaluate the association of VVV-FBG and M-FBG with all-cause mortality. The potential nonlinear associations were examined using restricted cubic splines, and additive interaction was evaluated using relative excess risk due to interaction (RERI). Cox generalized additive models (CGAMs) and bivariate response surface models were further used to assess the combined effects of VVV-FBG and M-FBG.
Results: A total of 4087 deaths were observed during a median follow-up of 6.99 years. Compared with patients with values at the 5th percentile of average real variability (ARV) and M-FBG, we observed a 23% and 38% increased risk of premature deaths among those with values at the 95th percentile of ARV (HR 1.23, 95% CI 1.10, 1.37) and M-FBG (HR 1.38, 95% CI 1.26, 1.51), respectively. The interaction between glycaemic variability (ARV) and M-FBG was significant on both the additive scale (RERI 0.80 [0.29, 1.32]) and the multiplicative scale (HR 1.90 [1.10, 3.28]). High VVV-FBG and high M-FBG conferred the highest risk of all-cause mortality (HR 1.89, 95% CI 1.64, 2.17), compared to low VVV-FBG and low M-FBG. The CGAMs showed significant synergistic effects between glycaemic variability and M-FBG (P < 0.05). Moreover, a bivariate surface plot showed that risk of death increased more rapidly in type 2 diabetes patients with lower M-FBG combined with lower VVV-FBG.
Conclusions: The coexistence of high glycaemic variability and high glucose level might exacerbate the independent risk of premature mortality in type 2 diabetes patients, highlighting the importance of achieving normal and stable glucose levels simultaneously in the management of glucose.
© 2022 John Wiley & Sons Ltd.
Similar articles
-
Long-term fasting glucose variability and risk of cancer in patients with type 2 diabetes mellitus: A retrospective population-based cohort study in Shanghai.J Diabetes. 2022 Nov;14(11):727-738. doi: 10.1111/1753-0407.13329. Epub 2022 Nov 9. J Diabetes. 2022. PMID: 36353746 Free PMC article.
-
Visit-to-Visit Glycemic Variability and Risks of Cardiovascular Events and All-Cause Mortality: The ALLHAT Study.Diabetes Care. 2019 Mar;42(3):486-493. doi: 10.2337/dc18-1430. Epub 2019 Jan 18. Diabetes Care. 2019. PMID: 30659073 Free PMC article. Clinical Trial.
-
Age and sex-specific associations of visit-to-visit variability of glycated hemoglobin A1c with all-cause mortality in patients with diabetes.Medicine (Baltimore). 2022 Aug 19;101(33):e29942. doi: 10.1097/MD.0000000000029942. Medicine (Baltimore). 2022. PMID: 35984136 Free PMC article.
-
Visit-to-Visit Variability in Fasting Blood Glucose Predicts the New-Onset Heart Failure: Results From Two Large Chinese Cohorts.Curr Probl Cardiol. 2023 Sep;48(9):101842. doi: 10.1016/j.cpcardiol.2023.101842. Epub 2023 May 25. Curr Probl Cardiol. 2023. PMID: 37244508 Review.
-
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.Pharmacoeconomics. 2004;22(6):389-411. doi: 10.2165/00019053-200422060-00005. Pharmacoeconomics. 2004. PMID: 15099124 Review.
Cited by
-
Risk prediction of diabetic retinopathy based on visit-to-visit fasting blood glucose indices.Front Endocrinol (Lausanne). 2024 Sep 20;15:1420948. doi: 10.3389/fendo.2024.1420948. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39371926 Free PMC article.
-
Hemoglobin glycation index and all-cause mortality in adults: insights from a decade-long prospective cohort study.Front Endocrinol (Lausanne). 2025 May 29;16:1586309. doi: 10.3389/fendo.2025.1586309. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40510488 Free PMC article.
References
REFERENCES
-
- Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the global burden of disease study. Lancet. 2020;395(10219):200-211. doi:10.1016/s0140-6736(19)32989-7.
-
- Maggio CA, Pi-Sunyer FX. Obesity and type 2 diabetes. Endocrinol Metab Clin North Am. 2003;32(4):805-822, viii. doi:10.1016/s0889-8529(03)00071-9.
-
- Amanat S, Ghahri S, Dianatinasab A, Fararouei M, Dianatinasab M. Exercise and type 2 diabetes. Adv Exp Med Biol. 2020;1228:91-105. doi:10.1007/978-981-15-1792-1_6.
-
- Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9(th) edition. Diabetes Res Clin Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843.
-
- Williams R, Karuranga S, Malanda B, et al. Global and regional estimates and projections of diabetes-related health expenditure: results from the international diabetes federation diabetes atlas, 9th edition. Diabetes Res Clin Pract. 2020;162:108072. doi:10.1016/j.diabres.2020.108072.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical